Intrexon | XON - Interest Income


Intrexon reported $319K in Interest Income for its fiscal quarter ending in June of 2024.





Interest Income Change Date
Arrowhead Research USD 16.87M 7.18M Mar/2026
AstraZeneca USD 80M 7M Jun/2026
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
Heron Therapeutics USD 433K 277K Dec/2021
Incyte USD 38.12M 4.43M Jun/2026
Intrexon USD 319K 602K Jun/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Ligand Pharmaceuticals USD 6.65M 262K Mar/2026
MacroGenics USD 1.55M 26K Mar/2026
MannKind USD 1.43M 208K Mar/2026
Merck USD 35M 34M Mar/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Thermo Fisher Scientific USD 233M 25M Mar/2026
Veracyte USD 3.48M 4K Mar/2026
Xencor USD 5.46M 741K Mar/2026